Home › Funds › MEYER HANDELMAN CO › GILD

MEYER HANDELMAN CO position in GILD

GILEAD SCIENCES INC · Health Care

MEYER HANDELMAN CO reported holding 311,663 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$46.5M, representing 1.33% of its reported portfolio and ranking #23 among its reported holdings. MEYER HANDELMAN CO has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)311.66K sh
Reported value held$46.45M
Portfolio Weight1.33%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How MEYER HANDELMAN CO's GILD position evolved

MEYER HANDELMAN CO first disclosed a stake in GILD in Q3 2023 at 392,354 shares (US$29.4M). The position peaked in Q1 2026 at 335,549 shares, worth US$46.8M. Across 13 filings, MEYER HANDELMAN CO increased the stake 0 time(s), trimmed it 8 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 311,663 shares valued at US$46.5M — a reduction of -4,974 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 392.35K $29.40M New
Q4 2023 391.50K $31.72M Hold
Q1 2024 392.11K $28.72M Hold
Q2 2024 383.37K $26.30M Reduce
Q3 2024 370.88K $31.09M Reduce
Q4 2024 369.18K $34.10M Hold
Q1 2025 365.52K $40.96M Reduce
Q2 2025 356.62K $39.54M Reduce
Q3 2025 347.37K $38.56M Reduce
Q4 2025 336.72K $41.33M Reduce
Q1 2026 335.55K $46.77M Hold
Q2 2026 316.64K $40.00M Reduce
Q3 2026 311.66K $46.45M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has MEYER HANDELMAN CO held GILD?

MEYER HANDELMAN CO has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MEYER HANDELMAN CO's current position in GILD?

As of Q3 2026, MEYER HANDELMAN CO holds 311.66K shares of GILD (GILEAD SCIENCES INC), valued at $46.45M, representing 1.33% of its reported portfolio and ranking #23.

Has MEYER HANDELMAN CO been buying or selling GILD?

In the latest 13F filing (Q3 2026), MEYER HANDELMAN CO reduced its position in GILD. The position peaked in Q1 2026 at 335.55K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.